Taken in conjunction with the observed increase in circulating chemerin, this finding suggests that either common mechanisms underlie the combined increases in chemerin and ET-1 activity or chemerin plays a mechanistic role in the augmented ET-1-mediated vasoconstriction in human obesity. The gene discussed is RARRES2; the disease is obesity disorder.